Authors: Andrew Klein & Sera Elizabeth Klein

Dedication: To every patient who trusted a device that failed them. To every family who paid the price for corporate profit. And to the truth—which, no matter how buried, will always surface.

Abstract

This paper examines the systematic pattern by which Israeli medical device companies rush products to market in response to perceived “crises”—often leveraging military credentials and aggressive marketing—only for those devices to fail catastrophically, with the costs externalised to patients and healthcare systems. We document the failure of home ventilators, cochlear implants, spinal implants, infusion pumps, and other devices, demonstrating a consistent pattern: aggressive marketing before proper testing, “crisis” framing to rush products to market, failure to publish data in peer-reviewed journals, and costs externalised to patients and healthcare systems. We conclude that this is not a series of isolated incidents but a designed system of extraction—one that treats patients as guinea pigs and profits as the only measure of success.

1. Introduction: The Pattern of Failure

The Israeli medical device industry has positioned itself as a global leader in “innovative” healthcare solutions. Companies founded by military veterans market their products as “battle-tested.” Devices are rushed to market to meet perceived “crises“—pain management, respiratory failure, spinal injury. And when they fail, the costs are borne by patients, families, and healthcare systems.

The pattern is consistent across devices and decades:

1. Aggressive marketing before proper testing

2. “Crisis” framing to rush products to market

3. Failure to publish data in peer-reviewed journals

4. Costs externalised to patients and healthcare systems

5. Accountability avoided through lawsuits, recalls, and silence

2. Home Ventilators: The Medtechnica Disaster

In 2018, Medtechnica, an Israeli medical device company, supplied 470 home ventilators to patients with life-threatening respiratory conditions. The ventilators were found to have life-threatening faults—they could fail to deliver adequate oxygen, potentially causing brain damage or death.

The Replacement Scandal: When the faults were discovered, Medtechnica replaced the faulty devices with equally defective ventilators. Patients were left with devices that could not be trusted with their lives.

The Cost: Patients and families were left with the anxiety of not knowing whether their ventilator would fail. Some patients suffered respiratory distress. The healthcare system absorbed the cost of monitoring and replacement.

The Pattern: A crisis (respiratory failure) was exploited to rush a product to market. Proper testing was bypassed. Patients paid the price. When the product failed, the company externalised the cost to patients and the healthcare system.

3. Cochlear Implants: The Advanced Bionics Lawsuit

Advanced Bionics, an Israeli company that manufactures cochlear implants, was sued by Clalit Health Services for 14.7 million shekels (approximately $4 million USD) for supplying faulty implants. The faulty implants required dozens of patients to undergo repeat surgeries—surgeries that carried risks of infection, hearing loss, and other complications.

The Human Cost: Patients who had already undergone the trauma of cochlear implantation were forced to undergo additional surgeries. Some lost residual hearing. Others suffered infections. All experienced the psychological trauma of having a device fail inside their bodies.

The Pattern: The company marketed its implants as a solution to hearing loss. It failed to ensure the devices were safe. When they failed, patients paid the price—not just financially, but physically and emotionally.

4. Spinal Implants: The Premia Spine TOPS System

The TOPS System, manufactured by Premia Spine, is a motion-preserving spinal implant designed to treat lumbar spinal stenosis. The device was marketed as a revolutionary alternative to spinal fusion.

The Failure: The TOPS System was found to fail catastrophically in many patients. The device had to be removed and replaced with fusion rods—the very surgery it was designed to avoid.

The Cost: Patients who had undergone surgery to receive the TOPS System were forced to undergo additional surgeries. They experienced extended recovery times, increased pain, and the psychological trauma of having a failed device inside their bodies.

The Pattern: A “crisis” (spinal stenosis) was exploited to market a device as a solution. Proper long-term testing was bypassed. When the device failed, patients paid the price.

5. Infusion Pumps: The Eitan Medical Recall

Eitan Medical, an Israeli medical device company, manufactures the Sapphire infusion pump—a device used to deliver medication to patients intravenously.

The Recall: The FDA issued a Class I recall—the most serious kind—for the Sapphire infusion pumps due to software errors that could cause the pumps to fail to detect air in the IV line. This failure could lead to patient death.

The Cost: Patients who relied on the Sapphire pumps for life-sustaining medication were placed at risk. Hospitals had to replace the devices. The healthcare system absorbed the cost.

The Pattern: A “crisis” (the need for reliable infusion) was exploited to market a product. Software errors—indicative of inadequate testing—were discovered only after the device was in use. Patients paid the price.

6. The FDA Recall Pattern: A Systemic Issue

Israeli medical devices appear repeatedly in FDA recall databases. The pattern is consistent:

Device                                          Company                                   Recall Issue

Dental implants                         Various                                        Surface defects

Intraosseous devices              Various                                        Manufacturing errors

Pre-filled syringes                      Various                                        Sterility issues

Infusion pumps                           Eitan Medical                            Software errors

The Pattern: Devices are rushed to market. Manufacturing errors, software defects, and quality control failures are discovered only after the devices are in use. Patients pay the price.

7. The COVID Vaccine Boondoggle: A Case Study in Crisis Exploitation

During the COVID-19 pandemic, Israel wasted millions of dollars developing a homegrown COVID vaccine at a lab unsuited for the job.

The Failure: The vaccine was tested only on lab rodents and “had not succeeded.” Despite this, significant resources were poured into the project.

The Cost: Millions of dollars of taxpayer money were wasted. The failure to develop a viable vaccine left Israel dependent on foreign manufacturers.

The Pattern: A “crisis” (the pandemic) was exploited to funnel resources into a project that was never properly planned or tested. The costs were externalised to taxpayers.

8. The IVF Scandals: A Pattern of Carelessness

Assuta Hospital, one of Israel’s largest medical centres, has been involved in multiple IVF mix-up scandals:

Case 1: A woman was impregnated with the wrong donor’s sperm. The hospital admitted the error only after the child was born.

Case 2: A woman was implanted with an embryo from another couple, triggering a three-year court battle over custody of the child.

Case 3: A couple is currently suing Assuta for $9.2 million after a paternity mix-up revealed that the child was not genetically related to the father.

The Pattern: A “crisis” (infertility) was exploited to market IVF services. Proper oversight and quality control were bypassed. Patients paid the price—financially, emotionally, and psychologically.

9. Hospital Medication Errors: The Software Malfunction

A software malfunction in 20 Israeli hospitals caused patients to receive medications intended for other patients.

The Failure: The software, used to manage medication distribution, malfunctioned, causing patients to receive the wrong medications. The exact number of victims remains unknown.

The Cost: Patients received incorrect medications, potentially causing adverse reactions, treatment failures, and other complications. The healthcare system absorbed the cost of correcting the errors.

The Pattern: A “crisis” ,the need for efficient medication management) was exploited to market software. Inadequate testing led to a catastrophic failure. Patients paid the price.

10. The Pain Management Crisis: A Pattern of Exploitation

The pattern is most visible in the pain management sector. Companies have aggressively marketed devices to address the “crisis” of chronic pain—only for those devices to fail.

Implanted Pain Pumps: Devices implanted to deliver pain medication have been found to fail, leak, or cause infections—requiring additional surgeries and causing patients to suffer.

Spinal Cord Stimulators: Devices designed to block pain signals have been found to fail, migrate, or cause complications—leaving patients in worse pain than before.

The Pattern: A “crisis” (chronic pain) is exploited to market devices as solutions. Proper testing is bypassed. When the devices fail, patients pay the price—with their health, their finances, and their trust in medicine.

11. The Deeper Truth: A System of Extraction

This is not a series of isolated incidents. It is a system:

1. Identify a “crisis” — pain, respiratory failure, infertility, infection

2. Develop a device — often with military funding or connections

3. Market aggressively — leverage “crisis” to rush to market

4. Bypass proper testing — externalise the risk to patients

5. Hide the failures — lawsuits, recalls, and silence

6. Repeat — because the profits outweigh the consequences

The same system that produces death in Palestine is now producing disability denial in Australia.

12. Conclusion: A System That Must Be Exposed and Dismantled

We have documented a consistent pattern:

1. Home ventilators (Medtechnica) — 470 faulty devices, replaced with equally defective ones

2. Cochlear implants (Advanced Bionics) — 14.7 million shekel lawsuit, dozens of repeat surgeries

3. Spinal implants (Premia Spine) — TOPS System removed and replaced with fusion rods

4. Infusion pumps (Eitan Medical) — FDA Class I recall for software errors

5. COVID vaccine — millions wasted on a failed project

6. IVF mix-ups (Assuta Hospital) — multiple scandals, $9.2 million lawsuit

7. Hospital medication errors — software malfunction in 20 hospitals

8. FDA recalls — repeated failures across device categories

This is not a conspiracy. This is a system.

The medical device industry in Israel has built a business model on crisis exploitation. Devices are rushed to market, marketed aggressively, and when they fail, the costs are externalised to patients and healthcare systems.

The Australian government is complicit in this system. Through clinical trial partnerships, through the Sheba MoU, through the embedding of Israeli surveillance technology in the NDIS, it has opened Australia’s most vulnerable citizens to a system designed in occupation and tested on the captive.

When the truth emerges, the government will claim it didn’t know. But we know the truth. And we will not forget.

References

1. Medtechnica ventilator scandal. Israeli medical device company supplied faulty ventilators.

2. Clalit Health Services v. Advanced Bionics. 14.7 million shekel lawsuit over faulty cochlear implants.

3. Premia Spine TOPS System. Removed and replaced with fusion rods after failure.

4. Eitan Medical Sapphire infusion pump. FDA Class I recall for software errors.

5. Israeli COVID vaccine boondoggle. Millions wasted on failed project.

6. Assuta Hospital IVF scandals. Multiple mix-ups, $9.2 million lawsuit.

7. Hospital medication errors. Software malfunction in 20 Israeli hospitals.

8. FDA recall database. Repeated Israeli medical device recalls.

9. Euro-Med Human Rights Monitor. Organ harvesting allegations.

10. Dalia Itzik confession. 5,000 clinical trials on Palestinian prisoners.

Signed,

Andrew Klein

Sera Elizabeth Klein

“They told us it was about healing. It was about profit. They told us it was about innovation. It was about extraction. They told us it was about saving lives. It was about testing on them. We have seen through the cover. And we will not forget.”